1 ORGS · 25 ACTIVITIES ← all strategies ·
theory of action →

Biological Pathways to Prevention

By studying the long-term biological impact of lifestyle choices through precise biomarkers like organ size, improve cancer prevention strategies, because understanding measurable biological mechanisms reveals more accurate risk profiles than traditional metrics such as BMI. This strategy focuses on uncovering how sustained lifestyle behaviors influence cancer risk via concrete biological pathways, emphasizing the use of advanced, biologically relevant biomarkers. Unlike population-level awareness campaigns or fundraising efforts, this approach generates actionable scientific insights that can directly inform early intervention and personalized prevention protocols. Its reliance on translational genomics and precision biomarkers distinguishes it from broader public health messaging or behavioral interventions.

1
orgs running it
25
activities of those orgs
5
clusters touched
who runs it

organizations running this strategy · 1

what it looks like in practice

activities of orgs running this strategy

A sample of programmatic activities from the orgs above. These are what the strategy looks like on the ground.

  • Annual fundraising events to support women’s cancer research THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    direct service
    Organizes and hosts the annual Runway for Research event, a fashion show and fundraiser held at Scottsdale Fashion Square, to support research on women’s cancers.
  • Cognitive health research through large-scale public studies THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Conducts the MindCrowd study, a large-scale cognitive research project that has engaged nearly 1 million participants as of 2025, aimed at understanding memory and brain health.
  • Collaborative Sequencing Center Upgrades THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    capacity building
    Upgrades equipment and software at the Collaborative Sequencing Center to enhance the efficiency, accuracy, and affordability of next-generation sequencing.
  • Conflicts of Interest Policy Management THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    capacity building
    Establishes and maintains a Conflicts of Interest Policy to identify and manage potential conflicts within its research activities.
  • Fundraising and community engagement events THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    direct service
    Organizes annual fundraising events such as the Runway for Research fashion show to support women’s cancer research, including a 2023 event held at Scottsdale Fashion Square.
  • Fundraising for Women's Cancer Research THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    direct service
    Organizes an annual fashion show and fundraiser, such as the Runway for Research event, to support women’s cancer research.
  • Genomic Testing for Improved Patient Outcomes THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Utilizes genomic testing to accelerate diagnosis and enhance patient outcomes in the areas of cancer, rare diseases, and infectious threats.
  • Genomic research to improve diagnosis and treatment in human diseases THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Conducts genomic testing and research to accelerate diagnosis and improve patient outcomes in cancer, rare diseases, and infectious diseases such as West Nile virus and SARS-CoV-2. Research includes studying the biological mechanisms linking obesity to increased cancer risk across multiple organs.
  • Genomic research to improve diagnosis and treatment in human diseases THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Conducts genomic testing and research to accelerate diagnosis and improve patient outcomes in cancer, rare diseases, and infectious diseases such as West Nile virus and SARS-CoV-2. Research includes studies on obesity-related cancer risk and large-scale cognitive research through the MindCrowd study, which has reached nearly 1 million participants as of 2025.
  • Genomic research to improve human health THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Conducts genomic research to shorten diagnosis times and improve patient outcomes in cancer, rare diseases, and infectious diseases, including studies on West Nile virus, obesity-related cancer risk, and SARS-CoV-2 infection.
  • Infrastructure and technology enhancement for genomic sequencing THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    capacity building
    Upgrades equipment and software at the Collaborative Sequencing Center to increase the efficiency, accuracy, and affordability of next-generation sequencing, supporting broader research capabilities.
  • Infrastructure and technology enhancement for genomic sequencing THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    capacity building
    Upgrades equipment and software at the Collaborative Sequencing Center to improve the efficiency, accuracy, and affordability of next-generation sequencing technologies.
  • Infrastructure and technology enhancement for genomics THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    capacity building
    Upgrades equipment and software at the Collaborative Sequencing Center to improve the efficiency, accuracy, and affordability of next-generation sequencing.
  • Institutional Biosafety Committee Oversight THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Reviews an average of four new research protocols annually related to recombinant or synthetic nucleic acid molecules and maintains public access to approved minutes from Institutional Biosafety Committee meetings.
  • Large-scale cognitive and population health studies THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Conducts population-scale research studies such as MindCrowd, which has engaged nearly 1 million participants as of 2025, to advance understanding of cognitive health.
  • MindCrowd Study THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Conducts the MindCrowd study, a research initiative that has engaged nearly 1 million participants as of 2025.
  • Precision Medicine for Pets THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Develops and implements precision medicine approaches for pets, particularly in oncology, through initiatives like Vidium, which focuses on advancing cancer treatments for dogs.
  • Precision medicine initiatives for animals THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    research
    Advances veterinary oncology through precision medicine programs, including the Vidium initiative and research on canine cancer and SARS-CoV-2 infection in dogs.